Egypt to receive first AstraZeneca vaccines Sunday

Egypt said Saturday the first doses of the coronavirus vaccine developed by Anglo-Swedish pharmaceutical giant AstraZeneca would arrive on Sunday.

Hundreds protest Amazon expansion in France

Hundreds rallied in several French towns on Saturday in protests against Amazon called by anti-capitalist and environmental groups, including at one site where the US e-commerce giant plans a massive warehouse.

Countries tighten borders against virus as US orders mask-wearing

A number of countries tightened their borders against a surge in variant strains of the deadly coronavirus as the United States on Saturday ordered travellers to wear masks on most public transport.

CDC requires face masks on airlines, public transportation

Travelers on airplanes and public transportation like buses and subways will be required to wear face masks starting next week to curb the spread of COVID-19.

As California virus cases fall, more people than ever dying

As a hospice nurse, Antonio Espinoza worked to ease people's passage into death. Just 36 years old, it seemed unlikely he soon would be on that journey.

Novavax COVID-19 vaccine news welcomed in South Africa

News that the Novavax COVID-19 vaccine has shown about 60% efficacy on HIV-positive patients and that it seems to work against the variant of the virus now dominant in South Africa is being welcomed with relief in the country, but further studies are urged.

WHO team visits 2nd Wuhan hospital in virus investigation

Members of a World Health Organization team investigating the origins of the coronavirus pandemic visited another Wuhan hospital that had treated early COVID-19 patients on their second full day of work Saturday.

Women undergo less aggressive open heart surgery, experience worse outcomes than men

Women are significantly less likely than men to undergo coronary artery bypass grafting (CABG) using guideline-recommended approaches, which may result in worse outcomes after surgery, according to a scientific presentation at the 57th Annual Meeting of The Society of Thoracic Surgeons.

'COVID effect' leads to fewer heart surgeries, more patient deaths

The most deadly global health crisis in a century has resulted in a substantial decline in overall heart surgery volume and an unexplained increase in deaths after coronary artery bypass grafting, according to late-breaking research presented at the 57th Annual Meeting of The Society of Thoracic Surgeons.

Nivolumab effective treatment for malignant mesothelioma

Nivolumab monotherapy is an effective treatment option for relapsed malignant mesothelioma (MM), according to research presented today at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.

Selected gene mRNA expression is not predictive of improved overall survival

A phase III study examining whether messenger (m)RNA expression correlated with sensitivity or resistance to chemotherapy did not confer a statistically significant advantage in overall survival for patients with resected stage II-III non-small cell lung cancer (NSCLC), according to research presented at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.

LCMC3: Neoadjuvant atezolizumab safe, meets primary endpoint of pathologic response rate

Primary analysis of the Lung Cancer Mutation Consortium (LCMC) 3 study revealed that neoadjuvant atezolizumab prior to lung cancer surgery was well tolerated by patients and met its primary endpoint of 20% major pathologic response rate, according to research presented today at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer.

TALENT study supports NLCST and NELSON trial results

A study presented today by researchers with the Ministry of Health and Welfare in Taiwan confirmed the effectiveness of low-dose computed tomography (LDCT) screening in a pre-defined, never-smoker, high-risk population. The research was presented today at the International Association for the Study of Lung Cancer 2021 World Conference on Lung Cancer.

AstraZeneca hit by COVID jab delays and disagreements

Only a few weeks ago, Anglo-Swedish pharmaceutical giant AstraZeneca was being applauded for the speed with which it developed its COVID-19 vaccine.

Brazil neighbors limit travel to halt virus strain's spread

Brazil's neighbors are starting to restrict international travel amid concern about the spread of a new coronavirus variant that experts say may be more contagious and driving a second wave of infections.

A look at COVID-19 vaccines already in use, or getting close

While a few have already hit the market, there are still dozens of coronavirus vaccines in development around the globe.

Seattle hospitals rush out vaccines after freezer failure

Seattle hospitals rushed out COVID-19 vaccines to hundreds of people in the middle of the night after a freezer they were being stored in failed.

Morocco starts vaccinating medics en masse against virus

Scores of Moroccan health workers streamed to a spacious white tent erected outside the Avicenne University Hospital in the capital Rabat to get their first dose of COVID-19 vaccines, as a mass vaccination effort began Friday in the North African country.

COVID-19 pandemic led to decreased school meal access for children in need across Maryland: study

School closures during COVID-19 have decreased access to school meals, which is likely to increase the risk for food insecurity among children in Maryland, according to a new report issued by researchers at the University of Maryland School of Medicine (UMSOM). The number of meals served to school-age children during the first three months of the pandemic dropped by 58 percent, compared to the number of free or reduced-price meals served the previous spring. As a result, thousands of children across the state were placed at increased risk of food insecurity, with many likely experiencing the health ramifications associated with the abrupt disruption in their access to regular meals.

Host immune classifier HIC assays may predict treatment response

Using a host immune classifier (HIC) test for patients with non-small cell lung cancer (NSCLC) may provide better predictors of treatment response and improve outcomes, according to research presented today at the International Association for the Study of Lung Cancer's 2020 World Conference on Lung Cancer Singapore.

Radiation Oncology trials using PET with FDG uptake among NSCLC patients

Two radiation oncology trials presented at the IALSC World Conference on Lung Cancer Singapore highlight how some researchers are exploring use of higher radiation boost doses to only PET-positive regions in locally-advanced non-small cell lung cancer (NSCLC). A previous large RTOG phase III trial revealed that the unform delivery of a high dose to the entire tumor led to poorer survival.

Adding ipilimumab to pembrolizumab does not improve efficacy in patients with NSCLC

Adding ipilimumab to pembrolizumab does not improve efficacy and is associated with greater toxicity than pembrolizumab alone as first-line therapy for metastatic non-small cell lung cancer (NSCLC) for patients with a PD-L1 tumor proportion score of greater than or equal to 50% and no targetable EGFR or ALK aberrations, according to research presented today at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer.

GameStop soars again; Wall Street bends under the pressure

Another bout of selling gripped the U.S. stock market Friday, as anxiety mounts over whether the frenzy behind a swift, meteoric rise in GameStop and a handful of other stocks will damage Wall Street overall.